| Peer-Reviewed

Clinical Case: Intestinal Perforation in Patient with SARS-COV-2 Infection

Received: 29 March 2022     Accepted: 14 April 2022     Published: 9 January 2023
Views:       Downloads:
Abstract

As the SARS-COV-2 virus pandemic spreads around the world, new clinical manifestations are being reported. In addition to respiratory manifestations, acute kidney injury, hypercoagulability, pulmonary thromboembolism, and gastrointestinal symptoms have been reported. The Infectology Hospital of the La Raza National Medical Center, in the Intensive Care Unit, has treated 148 patients from November 2020 to November 2021 for severe to critical COVID-19. We present the case of a patient with SARS-COV-2, with intestinal perforation due to vascular congestion at the level of the cecum in a critical COVID-19 patient.

Published in American Journal of Internal Medicine (Volume 11, Issue 1)
DOI 10.11648/j.ajim.20231101.11
Page(s) 1-4
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

COVID-19, SARS-COV-2, ACE2

References
[1] Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020; 92 (4): 401-2.
[2] Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019; 17: 181-92.
[3] De Nardi, P., Parolini, DC, Ripa, M., Racca, S. y Rosati, R. (2020). Perforación intestinal en un paciente con COVID-19: reporte de caso. Revista internacional de enfermedad colorrectal, 35 (9), 1797-1800.
[4] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506.
[5] L. Pan, M. Mu, P. Yang, et al. Características clínicas de pacientes con COVID-19 con síntomas digestivos en Hubei, China. Am J Gastroenterol, 115 (2020), págs. 766-773.
[6] K. Kotfis, K. Skonieczna-Żydecka. COVID-19: síntomas gastrointestinales y posibles fuentes de transmisión del SARS-CoV-2. Anaesthesiol Intensive Ther, 52 (2020), pp. 171-172.
[7] F. Xiao, M. Tang, X. Zheng, et al. Evidencia de infección gastrointestinal por SARS-CoV-2. Gastroenterología, 158 (2020), pp. 1831-1833.
[8] M. Panigada, N. Bottino, P. Tagliabue, et al. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost, 18 (2020), pp. 1738-1742.
[9] Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75 (7): 1730–41.
[10] Ren B, Yan F, Deng Z, Zhang S, Xiao L, Wu M, et al. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan. Circulation. 2020; 142: 181–3.
[11] Spiezia L, Boscolo A, Poletto F. COVID-19-Related Severe Hypercoagulability in Patients Admitted to the Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost. 2020; 120 (6): 998-1000.
[12] Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020; 1-12.
[13] Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J, et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi. 2020; 41 (0): E006.
[14] Nahas SC, Meira-JÚnior JD, Sobrado LF, Sorbello M, Segatelli V, Abdala E, Ribeiro-JÚnior U, Cecconello I. Intestinal perforation caused by COVID-19. Arq Bras Cir Dig. 2020 Nov 20; 33 (2): e1515. doi: 10.1590/0102-672020190001e1515. PMID: 33237160; PMCID: PMC7682143.
[15] Fan BE, Chang CCR, Teo CHY, Yap ES. COVID-19 Coagulopathy with Superior Mesenteric Vein Thrombosis Complicated by an Ischaemic Bowel. Hamostaseologie. 2020 Dec; 40 (5): 592-593. doi: 10.1055/a-1232-7446. Epub 2020 Sep 7. PMID: 32894875.
Cite This Article
  • APA Style

    Méndez-de Jesus Ignacio Alberto, Trejo-Rosas Saúl, Sanabria-Cordero David, Damián-Flores Sonia, Garcia-Roman Maria Teresa Arizbeth, et al. (2023). Clinical Case: Intestinal Perforation in Patient with SARS-COV-2 Infection. American Journal of Internal Medicine, 11(1), 1-4. https://doi.org/10.11648/j.ajim.20231101.11

    Copy | Download

    ACS Style

    Méndez-de Jesus Ignacio Alberto; Trejo-Rosas Saúl; Sanabria-Cordero David; Damián-Flores Sonia; Garcia-Roman Maria Teresa Arizbeth, et al. Clinical Case: Intestinal Perforation in Patient with SARS-COV-2 Infection. Am. J. Intern. Med. 2023, 11(1), 1-4. doi: 10.11648/j.ajim.20231101.11

    Copy | Download

    AMA Style

    Méndez-de Jesus Ignacio Alberto, Trejo-Rosas Saúl, Sanabria-Cordero David, Damián-Flores Sonia, Garcia-Roman Maria Teresa Arizbeth, et al. Clinical Case: Intestinal Perforation in Patient with SARS-COV-2 Infection. Am J Intern Med. 2023;11(1):1-4. doi: 10.11648/j.ajim.20231101.11

    Copy | Download

  • @article{10.11648/j.ajim.20231101.11,
      author = {Méndez-de Jesus Ignacio Alberto and Trejo-Rosas Saúl and Sanabria-Cordero David and Damián-Flores Sonia and Garcia-Roman Maria Teresa Arizbeth and Quiroz-Camacho Dulce Mariana},
      title = {Clinical Case: Intestinal Perforation in Patient with SARS-COV-2 Infection},
      journal = {American Journal of Internal Medicine},
      volume = {11},
      number = {1},
      pages = {1-4},
      doi = {10.11648/j.ajim.20231101.11},
      url = {https://doi.org/10.11648/j.ajim.20231101.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20231101.11},
      abstract = {As the SARS-COV-2 virus pandemic spreads around the world, new clinical manifestations are being reported. In addition to respiratory manifestations, acute kidney injury, hypercoagulability, pulmonary thromboembolism, and gastrointestinal symptoms have been reported. The Infectology Hospital of the La Raza National Medical Center, in the Intensive Care Unit, has treated 148 patients from November 2020 to November 2021 for severe to critical COVID-19. We present the case of a patient with SARS-COV-2, with intestinal perforation due to vascular congestion at the level of the cecum in a critical COVID-19 patient.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Clinical Case: Intestinal Perforation in Patient with SARS-COV-2 Infection
    AU  - Méndez-de Jesus Ignacio Alberto
    AU  - Trejo-Rosas Saúl
    AU  - Sanabria-Cordero David
    AU  - Damián-Flores Sonia
    AU  - Garcia-Roman Maria Teresa Arizbeth
    AU  - Quiroz-Camacho Dulce Mariana
    Y1  - 2023/01/09
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ajim.20231101.11
    DO  - 10.11648/j.ajim.20231101.11
    T2  - American Journal of Internal Medicine
    JF  - American Journal of Internal Medicine
    JO  - American Journal of Internal Medicine
    SP  - 1
    EP  - 4
    PB  - Science Publishing Group
    SN  - 2330-4324
    UR  - https://doi.org/10.11648/j.ajim.20231101.11
    AB  - As the SARS-COV-2 virus pandemic spreads around the world, new clinical manifestations are being reported. In addition to respiratory manifestations, acute kidney injury, hypercoagulability, pulmonary thromboembolism, and gastrointestinal symptoms have been reported. The Infectology Hospital of the La Raza National Medical Center, in the Intensive Care Unit, has treated 148 patients from November 2020 to November 2021 for severe to critical COVID-19. We present the case of a patient with SARS-COV-2, with intestinal perforation due to vascular congestion at the level of the cecum in a critical COVID-19 patient.
    VL  - 11
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Intensive Care of Infectology Hospital, National Autonomous University of Mexico, Mexican Institute of Social Security National Medical Center La Raza, Mexico City, Mexico

  • Departament of Pathology of the Specialty Hospital, National Autonomous University of Mexico, Mexican Institute of Social Security National Medical Center La Raza, Mexico City, Mexico

  • Department of Intensive Care of Infectology Hospital, National Autonomous University of Mexico, Mexican Institute of Social Security National Medical Center La Raza, Mexico City, Mexico

  • Department of Intensive Care of Infectology Hospital, National Autonomous University of Mexico, Mexican Institute of Social Security National Medical Center La Raza, Mexico City, Mexico

  • Department of Intensive Care of Infectology Hospital, National Autonomous University of Mexico, Mexican Institute of Social Security National Medical Center La Raza, Mexico City, Mexico

  • Departament of Pathology of the Specialty Hospital, National Autonomous University of Mexico, Mexican Institute of Social Security National Medical Center La Raza, Mexico City, Mexico

  • Sections